AU2001289735A1 - Chromenone derivatives and their use for treating diseases in conjunction with 5-HTA 1 receptors and/or dopamine D2 receptors - Google Patents
Chromenone derivatives and their use for treating diseases in conjunction with 5-HTA 1 receptors and/or dopamine D2 receptorsInfo
- Publication number
- AU2001289735A1 AU2001289735A1 AU2001289735A AU8973501A AU2001289735A1 AU 2001289735 A1 AU2001289735 A1 AU 2001289735A1 AU 2001289735 A AU2001289735 A AU 2001289735A AU 8973501 A AU8973501 A AU 8973501A AU 2001289735 A1 AU2001289735 A1 AU 2001289735A1
- Authority
- AU
- Australia
- Prior art keywords
- receptors
- hta
- dopamine
- conjunction
- treating diseases
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Psychiatry (AREA)
- Anesthesiology (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Pain & Pain Management (AREA)
- Diabetes (AREA)
- Heart & Thoracic Surgery (AREA)
- Obesity (AREA)
- Cardiology (AREA)
- Hospice & Palliative Care (AREA)
- Psychology (AREA)
- Gynecology & Obstetrics (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE10041574 | 2000-08-24 | ||
DE10041574A DE10041574A1 (de) | 2000-08-24 | 2000-08-24 | Chromenonderivate |
PCT/EP2001/008528 WO2002016354A1 (de) | 2000-08-24 | 2001-07-24 | Chromenonderivate und ihre verwendung zur behandlung von krankheiten im zusammenhang mit 5-hta1-rezeptoren und/oder dopamin-d2-rezeptoren |
Publications (1)
Publication Number | Publication Date |
---|---|
AU2001289735A1 true AU2001289735A1 (en) | 2002-03-04 |
Family
ID=7653636
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU2001289735A Abandoned AU2001289735A1 (en) | 2000-08-24 | 2001-07-24 | Chromenone derivatives and their use for treating diseases in conjunction with 5-HTA 1 receptors and/or dopamine D2 receptors |
Country Status (16)
Country | Link |
---|---|
US (1) | US20040014768A1 (zh) |
EP (1) | EP1311503A1 (zh) |
JP (1) | JP2004506733A (zh) |
KR (1) | KR20030022390A (zh) |
CN (1) | CN1447807A (zh) |
AU (1) | AU2001289735A1 (zh) |
BR (1) | BR0113364A (zh) |
CA (1) | CA2420206A1 (zh) |
CZ (1) | CZ2003659A3 (zh) |
DE (1) | DE10041574A1 (zh) |
MX (1) | MXPA03001609A (zh) |
NO (1) | NO20030811D0 (zh) |
PL (1) | PL359222A1 (zh) |
SK (1) | SK2942003A3 (zh) |
WO (1) | WO2002016354A1 (zh) |
ZA (1) | ZA200302255B (zh) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1408976B3 (en) | 2001-07-20 | 2010-08-25 | Psychogenics Inc. | Treatment for attention-deficit hyperactivity disorder |
DE10217006A1 (de) * | 2002-04-16 | 2003-11-06 | Merck Patent Gmbh | Substituierte Indole |
US7160888B2 (en) | 2003-08-22 | 2007-01-09 | Warner Lambert Company Llc | [1,8]naphthyridin-2-ones and related compounds for the treatment of schizophrenia |
EP1730730B1 (en) | 2004-03-26 | 2009-11-25 | LG Electronics, Inc. | Recording medium and method and apparatus for reproducing text subtitle stream recorded on the recording medium |
DE602005023285D1 (de) | 2004-03-26 | 2010-10-14 | Lg Electronics Inc | Speichermedium,verfahren, und gerät zum wiedergeben von untertiteldatenströmen |
WO2012087229A1 (en) * | 2010-12-20 | 2012-06-28 | Astrazeneca Ab | 2-carboxamide-4-piperazinyl-benzofuran derivative |
CN104059046B (zh) * | 2013-03-18 | 2017-02-08 | 江苏恩华药业股份有限公司 | 黄酮类衍生物及其应用 |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4704390A (en) * | 1986-02-13 | 1987-11-03 | Warner-Lambert Company | Phenyl and heterocyclic tetrahydropyridyl alkoxy-benzheterocyclic compounds as antipsychotic agents |
DE4111861A1 (de) * | 1991-04-11 | 1992-10-15 | Schwabe Willmar Gmbh & Co | Benzopyranone, verfahren zu ihrer herstellung und verwendung |
-
2000
- 2000-08-24 DE DE10041574A patent/DE10041574A1/de not_active Withdrawn
-
2001
- 2001-07-24 MX MXPA03001609A patent/MXPA03001609A/es unknown
- 2001-07-24 JP JP2002521455A patent/JP2004506733A/ja active Pending
- 2001-07-24 PL PL01359222A patent/PL359222A1/xx unknown
- 2001-07-24 EP EP01969491A patent/EP1311503A1/de not_active Withdrawn
- 2001-07-24 CN CN01814504A patent/CN1447807A/zh active Pending
- 2001-07-24 US US10/362,236 patent/US20040014768A1/en not_active Abandoned
- 2001-07-24 BR BR0113364-0A patent/BR0113364A/pt not_active Application Discontinuation
- 2001-07-24 AU AU2001289735A patent/AU2001289735A1/en not_active Abandoned
- 2001-07-24 CZ CZ2003659A patent/CZ2003659A3/cs unknown
- 2001-07-24 SK SK294-2003A patent/SK2942003A3/sk unknown
- 2001-07-24 WO PCT/EP2001/008528 patent/WO2002016354A1/de not_active Application Discontinuation
- 2001-07-24 CA CA002420206A patent/CA2420206A1/en not_active Abandoned
- 2001-07-24 KR KR10-2003-7002037A patent/KR20030022390A/ko not_active Application Discontinuation
-
2003
- 2003-02-21 NO NO20030811A patent/NO20030811D0/no unknown
- 2003-03-20 ZA ZA200302255A patent/ZA200302255B/en unknown
Also Published As
Publication number | Publication date |
---|---|
BR0113364A (pt) | 2003-07-15 |
JP2004506733A (ja) | 2004-03-04 |
US20040014768A1 (en) | 2004-01-22 |
NO20030811L (no) | 2003-02-21 |
SK2942003A3 (en) | 2003-09-11 |
WO2002016354A1 (de) | 2002-02-28 |
DE10041574A1 (de) | 2002-03-07 |
CN1447807A (zh) | 2003-10-08 |
CZ2003659A3 (cs) | 2003-06-18 |
MXPA03001609A (es) | 2003-06-04 |
KR20030022390A (ko) | 2003-03-15 |
CA2420206A1 (en) | 2003-02-21 |
PL359222A1 (en) | 2004-08-23 |
NO20030811D0 (no) | 2003-02-21 |
EP1311503A1 (de) | 2003-05-21 |
ZA200302255B (en) | 2004-08-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2002225356A1 (en) | Glucopyranosyloxypyrazole derivatives and use thereof in medicines | |
AU2001277754A1 (en) | Proline derivatives and use thereof as drugs | |
HUP0300746A3 (en) | Proline derivatives and use thereof as drugs | |
HK1062914A1 (en) | Glucopyranosyloxypyrazole derivatives and use thereof in medicines | |
AU2002222001A1 (en) | 3-arylindole derivatives and their use as CB2 receptor agonists | |
AU2001282267A1 (en) | Benzimidazole derivatives, preparation and therapeutic use thereof | |
GB0004167D0 (en) | 1-piperidinyl-propan-2-ol derivatives and their use as therapeutic agents | |
HUP0203961A3 (en) | 3-phenoxy-1-phenyl acetylene derivatives and their use as herbicedes | |
AU2001248365A1 (en) | 2-(arylalkylamino)pyrimidone derivatives and 2-(heteroarylalkylamino)pyrimidone derivatives | |
HUP0301773A3 (en) | Apomorphine derivatives and methods for their use | |
AU2001283285A1 (en) | Antimicrobial composition and methods of use in the treatment of disease | |
HU0001396D0 (en) | 3-amino-3-arylpropan-1-al derivatives and their use | |
AU2002343103A1 (en) | Aminoalkylimidazole derivatives and their use in medicine | |
AU2001289735A1 (en) | Chromenone derivatives and their use for treating diseases in conjunction with 5-HTA 1 receptors and/or dopamine D2 receptors | |
AU2001230355A1 (en) | Benzoxazole derivatives and their use as pesticides | |
AU2001235437A1 (en) | Isothiazolecarboxylic acid derivatives and their use as microbicides | |
AU5464901A (en) | Dichloropyridyl- and dichloroisothiazolyl-thiocarboxamides and their use as microbicides | |
AU2002231223A1 (en) | Compositions and methods for treating hematologic malignancies and multiple drug resistance | |
IL155853A0 (en) | Substituted cyclohexane derivatives and the use thereof in medicaments for treating cardiovascular diseases | |
AU2001261375A1 (en) | Human caspase-12 materials and methods | |
AU2002215187A1 (en) | S-adenosylmethionine and derivatives thereof for the treatment and prevention ofalzheimer's disease | |
SI1259515T1 (en) | Thienopyridine derivatives and their use as anti-inflammatory agents | |
AU2001235364A1 (en) | Tetrahydronaphtalene derivatives and their use | |
AU2001235829A1 (en) | Mutations in spink5 responsible for netherton's syndrome and atopic diseases | |
AU5974100A (en) | 6-carboxyphenyldihydropyridazinone derivatives and use thereof |